Norway health authority warns on falsified semaglutide pens
Reported from the analysis, not from a warning notice.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Lyophilisation
A gel pack has a finite thermal budget, and once it is spent the payload equilibrates with whatever is outside the box. The only question is how long that takes.
What the research-peptide trade calls a cold chain is, in the ordinary case, an insulated pouch, one or two frozen gel packs, and a transit estimate. That is not a criticism so much as a description, and it is worth understanding as an engineering problem rather than a moral one. A coolant pack has a fixed thermal budget determined by its mass and its latent heat of fusion. It absorbs heat leaking through the insulation until it has finished melting, and from that moment the payload begins tracking ambient temperature. A shipment either arrives before that point or it does not.
We ordered nine parcels of lyophilised material at catalogue prices, as ordinary customers, from suppliers we did not identify ourselves to, and arranged for a calibrated logger to travel inside the insulated payload of each. Eight arrived and produced complete traces. The ninth was held at a border for eleven days, exhausted its memory on day five, and arrived with a partial record and a cake that had visibly shrunk.
The headline results are in the table below. Transit times ran from two to nine days against quoted estimates of three to five. Five of the eight complete traces exceeded twenty-five degrees at some point; three exceeded thirty; the maximum recorded was thirty-eight degrees for three hours and forty minutes on a road leg. Mean kinetic temperature exceeded the arithmetic mean in every case, by between one and six degrees, with the largest gap on the trace with the shortest and hottest excursion — which is precisely the pattern the calculation is designed to expose.
Two of the eight arrived with their coolant packs still partly frozen, both on two-day domestic journeys. On the six longer journeys the coolant had fully melted and equilibrated, in most cases before the halfway point of the trip. We regard that as the central finding: for anything beyond about forty-eight hours, the gel pack is a delay rather than a control, and the shipment is relying on the material tolerating ambient temperature.
A gel pack works by latent heat. Water absorbs roughly three hundred and thirty-four joules per gram in melting, and while any solid remains the pack holds close to zero degrees. Once it has melted through, it has only sensible heat capacity left, about four joules per gram per degree, and it warms with the payload. The useful cold budget of a pack is therefore almost entirely its mass multiplied by the latent heat, and the transit time it buys is that budget divided by the rate at which heat leaks through the insulation.
The leak rate is where the arithmetic becomes discouraging. A thin expanded-polystyrene pouch has a modest thermal resistance and a large surface-to-volume ratio at parcel scale. A single two-hundred-gram pack in such a pouch, against an ambient temperature in the high twenties, is spent in something on the order of a day and a half. Two packs roughly double it. A vacuum-insulated shipper with a phase-change material would hold for several days, costs an order of magnitude more, and is not what arrives in this trade.
The honest conclusion is not that shipments in this market are catastrophic. It is that the cold chain they advertise is real for about the first day and notional thereafter, and that the practical protection for a multi-day journey is the intrinsic robustness of a dried peptide rather than anything in the packaging. The compendial guidance on distributing temperature-sensitive product is written around qualified shippers, mapped lanes and documented handover points, none of which exists here.1
Beyond about forty-eight hours the gel pack is a delay, not a control. After that the shipment is relying on the material.
On the coolant arithmeticOur ninth parcel entered a customs facility on a Thursday and left it eleven days later, released without explanation and without any record of the conditions in between. The logger, configured with a memory sufficient for a five-day journey at five-minute sampling, stopped recording on day five with the temperature at twenty-two degrees and rising through the afternoon. What happened over the following six days is unknown and cannot be reconstructed.
This is the least documented step in the supply chain and, when it occurs, routinely the longest. Examination facilities are not temperature-controlled, dwell time is not committed to, and neither shipper nor recipient receives a record. It follows that any claim of end-to-end temperature control on an international parcel of this kind cannot be true, because there is a segment during which nobody is measuring and nobody has authority to intervene.
The Journal reports this as a structural feature rather than a scandal. Customs authorities are performing a lawful function and are under no obligation to preserve the thermal history of a research chemical. But the consequence deserves to be stated plainly, because it is stated nowhere else: for a cross-border shipment, the shipper controls the first leg, the carrier controls the second, and there is a third leg over which nobody has visibility at all. Buyers reasoning about cold chain should reason about that leg.
| Intended storage | Long-term condition | Intermediate | Accelerated |
|---|---|---|---|
| Room temperature | 25 °C / 60% RH, ≥12 months | 30 °C / 65% RH | 40 °C / 75% RH, 6 months |
| Room temperature, hot climatic zone | 30 °C / 65% RH, ≥12 months | not applicable | 40 °C / 75% RH, 6 months |
| Refrigerated | 5 °C ± 3 °C, ≥12 months | not applicable | 25 °C / 60% RH, 6 months |
| Frozen | −20 °C ± 5 °C, ≥12 months | not applicable | single-batch excursion study |
| Below −20 °C | case by case | not applicable | single-batch excursion study |
| Summarised from the harmonised guideline on stability testing of new drug substances and products. Frozen-storage products are not accelerated in the usual sense; the guidance substitutes a study of the effect of a short excursion above the intended condition, which is precisely the data a shipped research vial would need and does not have. | |||
The alarmed version of this story would end with the excursions and leave the reader frightened. The evidence does not support that ending, and the Journal would rather publish the awkward finding than the satisfying one. A lyophilised peptide at low residual moisture, stored below its glass transition, has very little molecular mobility available for degradation. Short warm excursions in that state cost comparatively little, and the published solid-state stability literature is consistent on the point: dried peptides tolerate transient thermal insult far better than solutions do.
Two caveats keep this from being a licence. First, the protection depends on the cake being genuinely dry, which is the unmeasured variable this article keeps returning to. A cake at four per cent moisture has a much lower glass transition and much less margin. Second, repeated cycling is worse than a single excursion, particularly where a warm interval permits moisture redistribution within the cake or condensation inside the container on cooling.
The reordered risk list, on our reading, puts the reconstituted vial first, the cake with unknown residual moisture second, the multi-week domestic storage of an opened vial third, and the four hours at thirty-eight degrees in a courier van somewhere well below all of them. That ordering is not what the anxiety in this market reflects, and we think it is the more defensible one.2
The regulatory framework in this article is taken from the harmonised guidelines on stability testing and on biotechnological products, read in the original, and from the current compendial chapters on storage definitions, distribution of temperature-sensitive products and stability in dispensing practice. The degradation chemistry is drawn from the peptide and pharmaceutical sciences literature, and where a claim is a generalisation across sequences this piece says so, because sequence dependence is the rule rather than the exception.
The shipment data is ours. Nine parcels, ordered at catalogue prices as ordinary customers, with calibrated loggers placed inside the insulated payload and sampling at five-minute intervals. Eight complete traces and one truncated by a customs hold. We disclose that nine parcels is not a survey, that we did not control the packing operation, and that a single logger cannot characterise a payload with a thermal gradient across it.
Nothing in this department is a recommendation about storing, reconstituting or administering anything. The compounds discussed are sold for research use only and are not approved for human use in any jurisdiction. Corrections and disputes go to standards@compoundjournal.com; documents, traces and certificates readers would like examined go to letters@compoundjournal.com, and we do not identify the source of anything sent to us.
We will keep instrumenting parcels. Nine is not a survey and we said so before publishing the traces; the value of the exercise is that it establishes what a parcel actually experiences, at what cost, using instruments any buyer can obtain. Readers who have loggered their own shipments are invited to send the traces, with the placement stated.
Reported from the analysis, not from a warning notice.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Reported from the analysis, not from a warning notice.
The route did not close because of a rule about peptides.
A rotation scheme that is too complicated will not be followed. We describe the simple ones that are.
A substantial proportion of the abnormal results generated during rapid weight loss are consequences of the weight loss rather than findings about the person.